✦ LIBER ✦

Combination of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) has not only prognostic but also predictive impact in primary breast cancer

✍ Scribed by N. Harbeck; R. Kates; M. Look; C. Thomssen; F. Jänicke; J.G.M. Klijn; M. Kiechle; M. Schmitt; J. Foekens

Book ID: 114315588
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 197 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80063-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of urokinase pla

Prognostic significance of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer

✍ D Vrbanec; S Jelisavac-Cosic; J Jakic-Razumovic; E Mustac; I Kuzmic-Prusac 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Prognostic impact of urokinase-type plas

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

✍ de Witte, J H; Sweep, C G J; Klijn, J G M; Grebenschikov, N; Peters, H A; Look, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Pooled Analysis of Prognostic Impact of

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

✍ Look, M. P.; van Putten, W. L. J.; Duffy, M. J.; Harbeck, N.; Christensen, I. J. 📂 Article 📅 2002 🏛 Oxford University Press 🌐 English ⚖ 360 KB

Mutational analysis of the genes encodin

Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

✍ Beyhan Türkmen; Manfred Schmitt; Barbara Schmalfeldt; Paul Trommler; Wolfgang He 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors

✍ Maria E. L. van der Burg; Sonja C. Henzen-Logmans; Els M. J. J. Berns; Wim L. J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

Elevated levels of expression of the urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 have shown to be related to poor prognosis in a variety of cancer types. In the present study, cytosolic levels of uPA and PAI-1 were determined with enzyme-linked immunosorbent assays in cytosols

Prognostic value of tissue-type plasmino

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

✍ Witte, J H de; Sweep, C G J; Klijn, J G M; Grebenschikov, N; Peters, H A; Look, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB